Android app on Google Play

BofA/Merrill Lynch Downgrades Salix Pharmaceuticals (SLXP) to Neutral

July 3, 2013 7:54 AM EDT Send to a Friend
Get Alerts SLXP Hot Sheet
Price: $158.22 -0.56%

Rating Summary:
    17 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 13 | New: 52
Trade SLXP Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Neutral.

For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.

Shares of Salix Pharmaceuticals closed at $67.53 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment